Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4/A Registration of securities issued in business combination transactions
- 3.5 Form of Certificate of Domestication of Health Sciences Acquisitions Corporation 2, to Be Filed with the Secretary of State of Delaware
- 4.3 Specimen Common Stock Certificate of Orchestra Biomed Holdings, Inc
- 5.1 Opinion of Loeb & Loeb LLP
- 10.21 Form of Stock Option Grant Notice and Stock Option Agreement Under the Orchestra Biomed Holdings, Inc. 2023 Equity Incentive Plan
- 10.22 Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement Under the Orchestra Biomed Holdings, Inc. 2023 Equity Incentive Plan
- 23.1 Consent of Withumsmith+brown, PC, Independent Registered Public Accounting Firm of Health Sciences Acquisitions Corporation 2
- 23.2 Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm of Orchestra Biomed, Inc
- 99.8 Form of Proxy Card for Health Sciences Acquisitions Corporation 2 Extraordinary General Meeting
- Download Excel data file
- View Excel data file
Associated filings
- 19 Dec 22 EFFECT Notice of effectiveness
- 16 Dec 22 424B3 Prospectus supplement
-
12 Dec 22 S-4/A Registration of securities issued in business combination transactions (amended)
- 21 Nov 22 S-4/A Registration of securities issued in business combination transactions (amended)
- 21 Oct 22 S-4/A Registration of securities issued in business combination transactions (amended)
- 23 Sep 22 S-4/A Registration of securities issued in business combination transactions (amended)
- 8 Aug 22 S-4 Registration of securities issued in business combination transactions
OBIO similar filings
Filing view
External links
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated August 8, 2022, with respect to the consolidated financial statements of Orchestra BioMed, Inc. included in Amendment No. 4 to the Registration Statement (Form S-4 No. 333-266660) and related Prospectus of Health Sciences Acquisitions Corporation 2 for the registration of 33,726,395 shares of its common stock and 2,327,098 warrants.
/s/ Ernst & Young LLP
Philadelphia, Pennsylvania
December 12, 2022